Skip to content

Clinical trials

Aortic Valve Stenosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Aortic Valve Stenosis Country / region: China Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20144
20152
20161
20172
20184
20191
20206
20215
20225
20235
202410
202510
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting27
Unknown status13
Not yet recruiting7
Completed7
Enrolling by invitation4
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine7
China National Center for Cardiovascular Diseases6
Shanghai MicroPort CardioFlow Medtech Co., Ltd.6
Chinese Academy of Medical Sciences, Fuwai Hospital4
Xijing Hospital4
Beijing Anzhen Hospital3
Edwards Lifesciences3
Peijia Medical Technology (Suzhou) Co., Ltd.3
Novartis Pharmaceuticals2
Qilu Hospital of Shandong University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Aortic Valve Stenosis62
Aortic Valve Disease11
Aortic Valve Insufficiency9
Cardiovascular Diseases6
Bicuspid Aortic Valve Disease4
Heart Failure4
Heart Valve Diseases4
Dyslipidemias2
Heart Diseases2
Hypercholesterolemia2

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.